Revolutionizing Health with Fat-Directed DNA Therapy
At Infirmacea, our innovative DNA therapy utilizes safe and affordable plasmids, enhanced by our proprietary gBoost™ technology, to harness subcutaneous fat as a source of therapeutic proteins. This groundbreaking approach defines our fat-directed DNA therapy platform.
Our primary focus is addressing muscle weakness, including conditions such as sarcopenic obesity, frailty, and sarcopenia. Muscle loss can also result from weight-loss treatments like GLP-1 agonists, posing a significant challenge for patients. Muscle weakness often leads to severe health complications, particularly in aging populations. Yet, aside from exercise—which is not always feasible—no effective therapies currently exist to preserve healthy muscle mass and strength.
By developing therapeutic solutions that maintain muscle mass and functionality, we aim to empower individuals to age with vitality. With plans to expand our efforts into the anti-aging space, we are shaping a future where health and well-being remain a hallmark of life at any age.